Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8229)
All Articles published online
|
Publishing Process of This Article
|
Aug 24, 2020 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Barbalata CI, Tefas LR, Achim M, Tomuta I, Porfire AS. Statins in risk-reduction and treatment of cancer. World J Clin Oncol 2020; 11(8): 573-588 [PMID: 32879845 DOI: 10.5306/wjco.v11.i8.573] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i8/573.htm |
| Number | Citing Articles |
| 1 |
Xiaolin Jia, Ye Lu, Zili Xu, Qingqing Mu. Impact of statin use on breast cancer recurrence and mortality before and after diagnosis: a systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1256747
|
| 2 |
Duaa S. Nasereldin, Launia J. White, David O. Hodge, Lewis R. Roberts, Tushar Patel, Samuel O. Antwi. Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk. Digestive and Liver Disease 2022; 54(7): 964 doi: 10.1016/j.dld.2021.12.002
|
| 3 |
Antonio Rodríguez-Miguel, Encarnación Fernández-Antón, Diana Barreira-Hernández, Luis A. García-Rodríguez, Miguel Gil, Alberto García-Lledó, Francisco J. De Abajo. Statins and Colorectal Cancer Risk: A Population-Based Case-Control Study and Synthesis of the Epidemiological Evidence. Journal of Clinical Medicine 2022; 11(6): 1528 doi: 10.3390/jcm11061528
|
| 4 |
Archana Mishra, Pooja Gupta. Handbook of Oncobiology: From Basic to Clinical Sciences. 2023; : 1 doi: 10.1007/978-981-99-2196-6_77-1
|
| 5 |
Slight SH, Hyder SM. Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target?. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.1081151
|
| 6 |
Thomas Cash, Hunter C. Jonus, Maya Tsvetkova, Jan H. Beumer, Arhanti Sadanand, Jasmine Y. Lee, Curtis J. Henry, Dolly Aguilera, R. Donald Harvey, Kelly C. Goldsmith. A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors. Pediatric Blood & Cancer 2023; 70(8) doi: 10.1002/pbc.30405
|
| 7 |
Sambamoorthy Unnam, Arehalli S. Manjappa, Bhanoji Rao Muddana Eswara, Ahmad Salawi, Purushottam Gunti. Liposomal Melphalan: Approach to obtain improved plasma stability, pharmacokinetics, and in vitro and in vivo anticancer efficacy in combination with liposomal simvastatin against mouse RPMI-8226 multiple myeloma model. Journal of Drug Delivery Science and Technology 2022; 73: 103479 doi: 10.1016/j.jddst.2022.103479
|
| 8 |
Stefan Mark Nidorf, Abdallah Almaghraby, Yehia Saleh, Venkat R. Katkoori, Zain ul Abideen, Harvey L. Bumpers, Dorothy R. Pathak, George S. Abela. Cholesterol Crystals in Atherosclerosis and Other Related Diseases. Contemporary Cardiology 2023; : 413 doi: 10.1007/978-3-031-41192-2_22
|
| 9 |
Fung-Chang Sung, Ying-Chin Jong, Chih-Hsin Muo, Chih-Cheng Hsu, Wen-Chen Tsai, Yueh-Han Hsu. Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.815882
|
| 10 |
Hasan Ali Farhan, Israa Fadhil Yaseen, Mohammed Alomar, Daniel Lenihan, Susan Dent, Alexander R. Lyon. Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.979631
|
| 11 |
Chenliang Ge, Zhiyuan Jiang, Binghua Long, Qingjian Lu, Yan He. Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-18498-7
|
| 12 |
A. V. Smirnov, O. V. Gruzdeva, E. V. Pomeshkin, A. I. Bragin-Maltsev. Dyslipidemia and risk of prostate canсer in patients with urologic diseases. Fundamental and Clinical Medicine 2022; 7(1): 42 doi: 10.23946/2500-0764-2022-7-1-42-52
|
| 13 |
Jenna R. James, Johnathan Curd, Jennifer C. Ashworth, Mays Abuhantash, Martin Grundy, Claire H. Seedhouse, Kenton P. Arkill, Amanda J. Wright, Catherine L. R. Merry, Alexander Thompson. Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International Journal of Molecular Sciences 2023; 24(4): 4235 doi: 10.3390/ijms24044235
|
| 14 |
Magdalena Wujak, Anna Kozakiewicz, Anna Ciarkowska, Joanna I. Loch, Magdalena Barwiolek, Zuzanna Sokolowska, Marcin Budny, Andrzej Wojtczak. Assessing the Interactions of Statins with Human Adenylate Kinase Isoenzyme 1: Fluorescence and Enzyme Kinetic Studies. International Journal of Molecular Sciences 2021; 22(11): 5541 doi: 10.3390/ijms22115541
|
| 15 |
Martin G. Houston, Úna McMenamin, Brian Johnston, Ronald D. McDowell, Carmel M. Hughes, Peter Murchie, Chris R. Cardwell. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case‐control studies. British Journal of Clinical Pharmacology 2023; 89(9): 2757 doi: 10.1111/bcp.15759
|
| 16 |
Nazli Güllü, Janice Smith, Pia Herrmann, Ulrike Stein. MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer. Nutrients 2022; 14(22): 4792 doi: 10.3390/nu14224792
|
| 17 |
Laura Antonucci, Michael Karin. The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer Prevention Research 2024; 17(4): 141 doi: 10.1158/1940-6207.CAPR-23-0423
|
| 18 |
Danuta Szkutnik-Fiedler, Edyta Szałek, Filip Otto, Andrzej Czyrski, Marta Karaźniewicz-Łada, Anna Wolc, Edmund Grześkowiak, Konrad Lewandowski, Agnieszka Karbownik. Pharmacokinetic interaction between regorafenib and atorvastatin in rats. Pharmacological Reports 2024; doi: 10.1007/s43440-024-00570-z
|
| 19 |
Te-Chuan Chen, Chen-Wei Huang, Chih-Yu Lo, Cheng-Nan Chen, Shun-Fu Chang, Yih-Yuan Chen. Suppression of SREBP-1 Expression by Simvastatin Decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O Cells. Life 2022; 12(11): 1890 doi: 10.3390/life12111890
|
| 20 |
Jisha Pillai U, Anindita Ray, Meenu Maan, Mainak Dutta. Repurposing drugs targeting metabolic diseases for cancer therapeutics. Drug Discovery Today 2023; 28(9): 103684 doi: 10.1016/j.drudis.2023.103684
|
| 21 |
Ruby Kasana, Christy Thomas, Gaurav Das, Munlima Hazarika, Krishna Undela. Statin use and risk of cancer: An umbrella meta-analysis. Annals of Oncology Research and Therapy 2023; 3(1): 14 doi: 10.4103/aort.aort_34_22
|
| 22 |
Natalia Piekuś-Słomka, Lavinia Patricia Mocan, Rezarta Shkreli, Cristiana Grapă, Kinga Denkiewicz, Oliwia Wesolowska, Miroslaw Kornek, Zeno Spârchez, Artur Słomka, Rareș Crăciun, Tudor Mocan. Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer. Cancers 2023; 15(20): 5100 doi: 10.3390/cancers15205100
|
| 23 |
Fung-Chang Sung, Yi-Ting Yeh, Chih-Hsin Muo, Chih-Cheng Hsu, Wen-Chen Tsai, Yueh-Han Hsu. Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study. Cancers 2022; 14(3): 825 doi: 10.3390/cancers14030825
|
| 24 |
Iulia Rus, Mihaela Tertiș, Cristina Barbălată, Alina Porfire, Ioan Tomuță, Robert Săndulescu, Cecilia Cristea. An Electrochemical Strategy for the Simultaneous Detection of Doxorubicin and Simvastatin for Their Potential Use in the Treatment of Cancer. Biosensors 2021; 11(1): 15 doi: 10.3390/bios11010015
|
| 25 |
Unnam Sambamoorthy, Arehalli S. Manjappa, Bhanoji Rao Muddana Eswara, Arun Kumar Sanapala, Naidu Nagadeepthi. Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma. AAPS PharmSciTech 2022; 23(1) doi: 10.1208/s12249-021-02177-6
|
| 26 |
Samhita De, Sourav Paul, Anirban Manna, Chirantan Majumder, Koustav Pal, Nicolette Casarcia, Arijit Mondal, Sabyasachi Banerjee, Vinod Kumar Nelson, Suvranil Ghosh, Joyita Hazra, Ashish Bhattacharjee, Subhash Chandra Mandal, Mahadeb Pal, Anupam Bishayee. Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies. Cancers 2023; 15(3): 993 doi: 10.3390/cancers15030993
|
| 27 |
Amjad Z. Alrosan, Ghaith B. Heilat, Zeinab Y. Al Subeh, Khaled Alrosan, Alaa F. Alrousan, Amro K. Abu-Safieh, Nuwar S. Alabdallat. The effects of statin therapy on brain tumors, particularly glioma: a review. Anti-Cancer Drugs 2023; 34(9): 985 doi: 10.1097/CAD.0000000000001533
|
| 28 |
Akihiro Matsukawa, Takafumi Yanagisawa, Kensuke Bekku, Mehdi Kardoust Parizi, Ekaterina Laukhtina, Jakob Klemm, Sever Chiujdea, Keiichiro Mori, Shoji Kimura, Jun Miki, Benjamin Pradere, Juan Gomez Rivas, Giorgio Gandaglia, Takahiro Kimura, Veeru Kasivisvanathan, Guillaume Ploussard, Philip Cornford, Shahrokh F. Shariat, Pawel Rajwa. Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis. European Urology Oncology 2023; doi: 10.1016/j.euo.2023.10.010
|
| 29 |
Yara E Elakkad, Shimaa Nabil Senousy Mohamed, Nermeen Z Abuelezz. Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis. Breast Cancer: Targets and Therapy 2021; : 675 doi: 10.2147/BCTT.S336712
|
| 30 |
Asmara Ahmad, Sadia Javed, Shumaila Kiran. Statin as Repurposed Drug in Ovarian Cancer: A Comprehensive Review. Current Pharmaceutical Design 2023; 29(27): 2116 doi: 10.2174/1381612829666230913113808
|
| 31 |
Zhenzhou Xu, Liang Huang, Tao Dai, Xiaming Pei, Longzheng Xia, Gongqian Zeng, Mingji Ye, Kan Liu, Fuhua Zeng, Weiqing Han, Shusuan Jiang. SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer. OncoTargets and Therapy 2021; : 4285 doi: 10.2147/OTT.S315813
|
| 32 |
Samar A. Dewidar, Omar Hamdy, Ahmed Eltantawy, Mohamed El-Mesery, Amal M. El Gayar, Moetaza M. Soliman. Effect of concomitant use of pitavastatin with neoadjuvant chemotherapy protocols in breast cancer patients: A randomized controlled clinical trial. Saudi Pharmaceutical Journal 2022; 30(10): 1486 doi: 10.1016/j.jsps.2022.07.011
|
| 33 |
Sabya Sachi Das, Sandeep Kumar Singh, P.R.P. Verma, Rekha Gahtori, Belay Zeleke Sibuh, Kavindra Kumar Kesari, Niraj Kumar Jha, Sugapriya Dhanasekaran, Vijay Kumar Thakur, Ling Shing Wong, Sinouvassane Djearamane, Piyush Kumar Gupta. Polyester nanomedicines targeting inflammatory signaling pathways for cancer therapy. Biomedicine & Pharmacotherapy 2022; 154: 113654 doi: 10.1016/j.biopha.2022.113654
|
| 34 |
Samin Ghorbani Moghadam, Mehrshad Ebrahim Pour, Seyedeh Hoda Alavizadeh, Prashant Kesharwani, Amirhossein Sahebkar. The association between oxidized low-density lipoprotein and cancer: An emerging targeted therapeutic approach?. Bioorganic & Medicinal Chemistry Letters 2024; : 129762 doi: 10.1016/j.bmcl.2024.129762
|
| 35 |
Mohamed Y. Zaky, Chuanwen Fan, Huan Zhang, Xiao-Feng Sun. Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance. Cancers 2023; 15(19): 4787 doi: 10.3390/cancers15194787
|
| 36 |
Talar S. Habeshian, Yu‐Hsiang Shu, Kimberly L. Cannavale, Jeff M. Slezak, Gary W. Chien, Stephen K. Vandeneeden, Chun R. Chao. Exposure to statins post localized prostate cancer diagnosis and risk of metastasis among men who did not receive curative prostate cancer treatment. Cancer Reports 2023; 6(3) doi: 10.1002/cnr2.1749
|
| 37 |
Mithila Tennakoon, Waruna Thotamune, John L. Payton, Ajith Karunarathne. CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions. Journal of Biological Chemistry 2023; 299(11): 105269 doi: 10.1016/j.jbc.2023.105269
|
| 38 |
Zahra Shaghaghi, Maryam Alvandi, Soghra Farzipour, Mohammad Reza Dehbanpour, Sahar Nosrati. A review of effects of atorvastatin in cancer therapy. Medical Oncology 2022; 40(1) doi: 10.1007/s12032-022-01892-9
|
| 39 |
Ana Salomé Correia, Lara Marques, Nuno Vale. The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin. Current Issues in Molecular Biology 2023; 45(4): 3333 doi: 10.3390/cimb45040218
|
| 40 |
Vijay Kumar, John H. Stewart. Obesity, bone marrow adiposity, and leukemia: Time to act. Obesity Reviews 2024; 25(3) doi: 10.1111/obr.13674
|
| 41 |
Patricia Guerrero-Ochoa, Sergio Rodríguez-Zapater, Alberto Anel, Luis Mariano Esteban, Alejandro Camón-Fernández, Raquel Espilez-Ortiz, María Jesús Gil-Sanz, Ángel Borque-Fernando. Prostate Cancer and the Mevalonate Pathway. International Journal of Molecular Sciences 2024; 25(4): 2152 doi: 10.3390/ijms25042152
|
| 42 |
Magdalena Staszczak. Fungal Secondary Metabolites as Inhibitors of the Ubiquitin–Proteasome System. International Journal of Molecular Sciences 2021; 22(24): 13309 doi: 10.3390/ijms222413309
|
| 43 |
Prasoona Karra, Maci Winn, Svenja Pauleck, Alicja Bulsiewicz‐Jacobsen, Lacie Peterson, Adriana Coletta, Jennifer Doherty, Cornelia M. Ulrich, Scott A. Summers, Marc Gunter, Sheetal Hardikar, Mary C. Playdon. Metabolic dysfunction and obesity‐related cancer: Beyond obesity and metabolic syndrome. Obesity 2022; 30(7): 1323 doi: 10.1002/oby.23444
|
| 44 |
Stefan A. Lange, Christoph Schliemann, Christiane Engelbertz, Jannik Feld, Lena Makowski, Joachim Gerß, Patrik Dröge, Thomas Ruhnke, Christian Günster, Holger Reinecke, Jeanette Köppe. Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis. Cancers 2023; 15(20): 4966 doi: 10.3390/cancers15204966
|
| 45 |
Daniela Mengual, Luz Elena Medrano, Wendy Villamizar-Villamizar, Estefanie Osorio-Llanes, Evelyn Mendoza-Torres, Samir Bolívar. Novel Effects of Statins on Cancer via Autophagy. Pharmaceuticals 2022; 15(6): 648 doi: 10.3390/ph15060648
|
| 46 |
Chiharu Miyajima, Yurika Hayakawa, Yasumichi Inoue, Mai Nagasaka, Hidetoshi Hayashi. HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals 2022; 15(8): 1015 doi: 10.3390/ph15081015
|
| 47 |
Khatereh Anbari, Mehdi Mohammadian Amiri, Saeid Heidari-Soureshjani, Catherine MT Sherwin, Karamali Kasiri. A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of
Mortality Following Pancreatic Cancer. Anti-Cancer Agents in Medicinal Chemistry 2023; 23(19): 2073 doi: 10.2174/1871520623666230824095226
|
| 48 |
A.V. Smirnov, E.B. Brusina, Yu.A. Magaryll, L.A. Gordeeva. Epidemiological analysis of prostate cancer risk factors. Profilakticheskaya meditsina 2022; 25(8): 75 doi: 10.17116/profmed20222508175
|
| 49 |
Emanuela Chiarella, Clelia Nisticò, Anna Di Vito, Helen Linda Morrone, Maria Mesuraca. Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs. Biomedicines 2022; 10(5): 1146 doi: 10.3390/biomedicines10051146
|
| 50 |
Athiban Inbarajan, Mubeena S, Alan Mathew Punnoose, Giri GVV, Anusha D, Jasline David J. Effects of Simvastatin on Gene Expression and Alkaline Phosphatase Activity in the MG-63 Cell Line Treated With Hyperglycemia for Bone Regeneration . Cureus 2024; doi: 10.7759/cureus.55482
|
| 51 |
Beniamin Oskar Grabarek, Dariusz Boroń, Emilia Morawiec, Piotr Michalski, Veronica Palazzo-Michalska, Łukasz Pach, Barbara Dziuk, Magdalena Świder, Nikola Zmarzły. Crosstalk between Statins and Cancer Prevention and Therapy: An Update. Pharmaceuticals 2021; 14(12): 1220 doi: 10.3390/ph14121220
|
| 52 |
Sara Mikhael, Abdullah Kurdi, Nathalie Khoueiry-Zgheib, Roula Tahtouh, Rihab Nasr, George Hilal, Chien-Feng Li. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells. PLOS ONE 2024; 19(3): e0298127 doi: 10.1371/journal.pone.0298127
|
| 53 |
Maria Błaszczyk, Agata Kozioł, Anna Palko-Łabuz, Kamila Środa-Pomianek, Olga Wesołowska. Modulators of cellular cholesterol homeostasis as antiproliferative and model membranes perturbing agents. Biochimica et Biophysica Acta (BBA) - Biomembranes 2023; 1865(6): 184163 doi: 10.1016/j.bbamem.2023.184163
|